Over 1.2 million people sign petition to EU calling for financial support for abortions
The
My Voice, My Choice
campaign started collecting signatures exactly a year ago and today is the last day that people can add their support.
This is a European Citizens' Initiative, which, if over one million are collected, requires the EC to officially reply to the petition, outlining its legal and political conclusions as well as any actions it will take in response.
The campaign aims to 'make women's lives freer, safer, and better; wherever they live in our union'.
Veronika Povž, communication director of the campaign said that 'those with enough money can travel for an abortion — there's always a way for them'.
But it's the marginalised groups and those who can't afford it who suffer the most.
Instead of interfering with laws and regulations of Member States, the initiative instead asks the Commission:
'To submit a proposal for financial support to Member States that would be able to perform safe termination of pregnancies, in accordance with their domestic law, for anyone in Europe who still lacks access to safe and legal abortion.'
It proposes that this would be a voluntary 'opt-in mechanism' for each country.
Effectively, that means that support would be provided in countries with more liberal abortion access to enable them to provide care for women travelling from areas with more restrictive laws.
Advertisement
Thousands of women continue to travel to access care, as reported by
The Journal Investigates
earlier this month in our
Exporting Abortion
investigation.
We revealed that
over 5,000 women in Europe travel from their home countries
across borders for abortions each year.
Few successful citizens' campaigns
More than a decade after the creation of the European Citizens' Initiative, the EU's common petitioning system, it is clear that gathering a million signatures for or against a cause is a major challenge.
Even among the 27 million inhabitants of the EU, to reach this high bar requires a lot of campaigning and funding.
Each country has set thresholds for signature number, dependent on population size, and campaigns must get support from at least seven EU countries to be considered.
For this pro-choice initiative, 19 out of the 27 Member States were over their set threshold. That included over 12,500 people from Ireland, far more than the 9,165 threshold.
The highest number of signatures per population came from Slovenia (over 65,000) where the campaign started. Over 200,000 signed the initiative in France, with over 150,000 from Germany and Italy.
Bulgaria, Luxembourg and Lithuania had the lowest proportion of signatures.
Significant funding was required to get over the line. My Voice, My Choice declared over €830,000 in sponsorship since February last year.
However, though this particular campaign has successfully collected the required signatures, it is only the 11th European Citizens' Initiative to do so since it started 13 years ago.
In that time, 95 initiatives have failed — 68 failed to obtain the required signatures and 27 were withdrawn by their initiators — out of a total of 119 accepted by the European Commission to collect signatures.
Related Reads
'I'll never forgive my country': Women on the trauma of having to travel to UK for terminations
'The most vulnerable are still being exported': Why and how women have to travel for abortions
Over 5,000 women in Europe have to travel abroad for abortions each year
Signatures to be verified
The pro-choice campaign is not done yet as the next step once the signature collection closes later today is verification.
A Commission spokesperson told us that 'Member States will have 3 months to perform the verification' of the statements of support.
Once that is done, and there are at least one million signatures remaining, then My Voice, My Choice can submit it to the EC for examination. The Commission then has six months to officially reply. The spokesperson said:
'Where the Commission intends to take action in response to the initiative, including, where appropriate, the adoption of one or more proposals for a legal act of the Union, the Communication shall also set out the envisaged timeline for these actions.'
—
Maria Delaney is the editor of
The Journal Investigates
.
This article was produced in the framework of the
PULSE
cross-border journalistic cooperation project. It was developed with György Folk, Brussels (EUrologus) and Viktória Serdült (HVG) Budapest.
Our investigative unit is dedicated to lifting the lid on how Ireland works. This takes time and it takes resources. Find out how you can help:
Support The Journal Investigates
Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article.
Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.
Learn More
Support The Journal
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Journal
2 hours ago
- The Journal
Trump's planning 250% tariffs on pharmaceuticals - and he hasn't forgotten about Ireland
LAST UPDATE | 1 hr ago TARIFFS ON IMPORTED pharmaceuticals into the US could go as high as 250%, President Donald Trump has said. Pharmaceuticals and semiconductors will be the next industries targeted in the latest round of Trump's tariffs, he outlined today, despite the EU claiming that it had agreed a 15% tariff cap on medicines. Speaking to CNBC this morning, Trump referenced Ireland's strength in the pharmaceuticals sector, and indicated that new tariffs on imported pharmaceuticals and semiconductors will be announced soon – potentially in the coming week. He said that other countries 'make a fortune with pharmaceuticals', 'They make our pharmaceuticals in China and Ireland,' he said, adding that upcoming tariffs on imported pharmaceuticals could reach 250%. 'We'll be putting [an] initially small tariff on pharmaceuticals, but in one year, one-and-a-half years, maximum, it's going to go to 150%, and then it's going to go to 250% because we want pharmaceuticals made in our country,' he said. Advertisement CNBC Television / YouTube '15% cap is all-inclusive' Trump and European Commission President Ursula von der Leyen agreed a deal two weeks ago to a baseline US tariff of 15% on imports from the EU. It left out some sectors, though, including pharmaceuticals. Today, the European Commission pushed back on criticism from members of the German government that von der Leyen had not secured a good deal for businesses and citizens in the EU. Similar criticism was levelled in a recent episode of The Journal 's The Explainer p odcast, when economist and TU Dublin lecturer Emma Howard said Trump successfully 'anchored' his negotiations with the EU, which saw Europe talk him down from a proposed and unrealistic 30% tariff rate. Trade spokesperson Olof Gill stood over the agreement between the Commission President and Trump, claiming the deal secured a future without further tariffs and assured that the 15% tariff ceiling on goods 'is all-inclusive'. He said that the deal allows the EU and the US to have a 'stable platform' to move towards a zero-for-zero tariff scenario, secure future trade deals with Washington and provide certainty to businesses. His comments came after he confirmed that the European Commission today waived Europe's proposed counter tariffs against the US – despite previous claims from the EU's executive that it would move forward with reciprocal measures should tariffs be imposed. Future of tariffs on pharma Uncertainty remains, however, for the pharma industry – a lucrative sector for Ireland. In April, the Trump White House initiated new investigations into the imports of pharmaceuticals under Section 232 of the Trade Expansion Act. Read Next Related Reads Q&A: What we know (and don't know) about the EU-US tariff deal 'Resorted to submission': Last-minute US tariff deal earns stinging criticism from EU leaders Are pharmaceuticals part of the EU-US tariff deal? And what's Section 232 got to do with it? The purpose of a Section 232 investigation is to determine, in short, the effect of imports on US national security and whether certain imports 'threaten to impair' national security. Its outcome will determine if placing tariffs on goods such as medicines, which the US largely imports, threatens the security of the American job market, economic growth or foreign direct investment, monetary or otherwise. Trump's plans have incited concerns overseas, as governments that expect to be hit the most try to appease him to avoid high tariff leaders are due to travel to Washington DC today for talks to try to swerve a 39% tariff due Thursday. Similarly to Ireland, pharmaceuticals represent a large majority (60%) of Swiss goods that are exported to the US. Additional reporting by AFP and Muiris Ó Cearbhaill Readers like you are keeping these stories free for everyone... A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation. Learn More Support The Journal
Irish Examiner
4 hours ago
- Irish Examiner
EU to appoint diplomat to help with efforts to free Gena Heraty
The EU will appoint a diplomat in Haiti to help in Irish efforts to free Gena Heraty and other hostages. It comes as the family of the kidnapped charity worker asked people to keep her in their hearts and pray for her safe and speedy return. Ms Heraty, from Westport, Co Mayo, was one of eight people seized from the Sainte-Hélène orphanage, about 10km from Port-au-Prince. As diplomatic efforts continue to secure her release, the Mayo woman's family issued a statement on Tuesday night through the Department of Foreign Affairs, saying they are still coming to terms with what has happened. 'We continue to work closely with Nos Petits Frères et Soeurs (NPFS) in Haiti and Ireland, the Department of Foreign Affairs and Trade, and international partners who have all assured us that everything possible is being done to get Gena, and those taken with her, safely released as soon as possible,' the family said. 'Gena is loved and respected by so many people, as is evident in the outpouring of concern, support and prayers from everyone near and far. "We are truly so grateful for all the messages of support we have received over the past few days," they added. Earlier, Tánaiste and foreign affairs minister Simon Harris held talks his Haitian counterpart, Jean-Victor Harvel Jean-Baptiste, and said the minister assured him of his support in their work to ensure the safe release of Ms Heraty and all the hostages. Special point of contact Mr Harris has raised the case with the EU's high representative for foreign affairs and security policy, Kaja Kallas. Ms Kallas supported the Tánaiste's request for the EU to designate a specific point of contact in Haiti, working directly with Ireland on the ongoing efforts to free Gena and the other hostages. The EU currently has a team of representatives based in Haiti. A spokesman said the Tánaiste has been in 'constant contact with the Heraty family, and updated them on these developments'. They also stated that 'different avenues at both political and diplomatic level continue to be exhausted as part of the ongoing efforts to secure Gena'. " The kidnapping of Gena Heraty, her co-workers, and a three-year-old child is utterly devastating,' Mr Harris said. 'This is a particularly difficult time for the Heraty family. My Department and I will continue to provide them whatever support they need. "I was glad to secure the full backing of the EU's high representative for foreign affairs and security policy, Kaja Kallas. She has agreed to immediately put in place measures to support Ireland in relation to this case. "This is an important development, ensuring that this case is firmly on the agenda of the European Union and our EU colleagues," he added.
Irish Times
7 hours ago
- Irish Times
Lobby other EU countries to allow Irish Central Bank to drop Israeli war bonds, TDs recommend
An Oireachtas committee has recommended the Government lobby other EU states to change rules that stop the Irish Central Bank from refusing to act as a competent authority in Europe for Israeli war bonds. Third-country issuers, such as Israel, can choose any EU state as their home member state and competent authority. That authority reviews its bond prospectus and, in this case, authorises Israel to sell bonds in the EU market. Before 2021, the UK was the EU home member state under the regulation for the state of Israel. Ireland was chosen as the new home member state following the UK's departure from the EU after Brexit in 2016. Politicians from all parties have expressed concern that Ireland is the competent authority that gives authority to Israel to sell bonds in the EU market, including what Israel markets as 'war bonds'. However, the committee has been told by the Central Bank that it is powerless to refuse to act as the competent authority under current rules. The rules and criteria that determine approval of the prospectus do not cover Israel's continuing military activities in Gaza , but rather include risk rules based on financial and fiscal criteria. The governor of the Central Bank, Gabriel Makhlouf, told the Oireachtas Committee on Finance in June that Ireland had no power to unilaterally remove itself from being the competent authority. Any decision to change that situation, he said, would be made by the third country, in this case Israel, and by that third country alone. The committee, chaired by Sinn Féin TD Mairéad Farrell , published a report on Tuesday, the main recommendation of which was that the Government engage at EU level with a 'view to amending the EU Prospectus regulations to permit each individual European Central Bank to refuse to act as a Competent Authority'. It has also recommended that the Central Bank conduct an immediate internal review in advance of any renewal in September of the Israeli bond prospectus. It said that review should determine whether it is in compliance with the levels of disclosure, accuracy and transparency required by the EU Prospectus. At the meeting in June, committee members expressed concern that the continuing destruction and deaths in Gaza were not being taken into consideration in determining the right of Israel to sell bonds, which several committee members pointed out were being openly marketed as 'war bonds'. The report states: 'In response to questions around whether enhanced scrutiny is applied to sovereign bond issuers involved in armed conflict or under international investigation, representatives of the Central Bank told the Committee that a judgement is made as to whether a prospectus is particularly complex and if there are issues that are challenging to articulate. 'Ultimately, however, the judgement rests on whether the disclosure is appropriate to the financial risk.' At the meeting, members expressed concern with regard to both the exposure of the EU financially to Israel and the current situation in Israel. 'Members further described the prospectus regulatory regime as 'narrow and arguably amoral ... Jesuitical in the way that it is interpreted and applied, which is mindful of only its basic, legalistic obligations in satisfying the regulatory framework in place', the report stated. Amid cross-party opposition to the Central Bank continuing in that role, the committee has also recommended that any future review of its role as the competent authority by the regulator should take into account the nature of the case taken by South Africa against Israel under the Genocide Convention and the interim findings of the International Court of Justice (ICJ) in that regard. It also said the illegal situation created by Israel in the Occupied Palestinian Territories should also be taken into account.
